West Branch Capital LLC Abbott Laboratories Transaction History

West Branch Capital LLC

$274 Million
Q3 2024

A detailed history of West Branch Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, West Branch Capital LLC holds 15,335 shares of ABT stock, worth $1.81 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

15,335

Previous 15,605 1.73%

Holding current value

$1.81 Million

Previous $1.62 Million 7.83%

% of portfolio

0.64%

Previous 0.63%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $27,018 - $31,895	-270 Reduced 1.73%	15,335 $1.75 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $21,556 - $24,062	-214 Reduced 1.35%	15,605 $1.62 Million
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $158,475 - $175,029	1,447 Added 10.07%	15,819 $1.8 Million
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $35,083 - $42,945	-389 Reduced 2.64%	14,372 $1.58 Million
Q3 2023 Oct 20, 2023	BUY	$95.53 - $114.62 $2,865 - $3,438	30 Added 0.2%	14,761 $1.43 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $28,722 - $32,002	285 Added 1.97%	14,731 $1.61 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $21,309 - $25,082	220 Added 1.55%	14,446 $1.46 Million
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $1,235 - $1,449	13 Added 0.09%	14,226 $0
Q3 2022 Oct 19, 2022	BUY	$96.76 - $112.03 $3,580 - $4,145	37 Added 0.26%	14,213 $1.38 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $5,817 - $7,032	-57 Reduced 0.4%	14,176 $1.54 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $6,043 - $7,369	-53 Reduced 0.37%	14,233 $1.69 Million
Q4 2021 Jan 24, 2022	BUY	$115.53 - $141.46 $45,980 - $56,301	398 Added 2.87%	14,286 $2.01 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $9,682 - $10,711	83 Added 0.6%	13,888 $1.64 Million
Q2 2021 Aug 17, 2021	BUY	$105.79 - $124.53 $68,234 - $80,321	645 Added 4.9%	13,805 $1.6 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $27,318 - $32,185	-251 Reduced 1.87%	13,160 $1.58 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $28,245 - $30,778	269 Added 2.05%	13,411 $1.47 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $35,373 - $42,957	386 Added 3.03%	13,142 $1.43 Million
Q2 2020 Jul 08, 2020	BUY	$76.57 - $98.0 $276,877 - $354,368	3,616 Added 39.56%	12,756 $1.17 Million
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $12,061 - $17,637	192 Added 2.15%	9,140 $721,000
Q4 2019 Jan 07, 2020	BUY	$78.51 - $87.4 $259,946 - $289,381	3,311 Added 58.74%	8,948 $777,000
Q3 2019 Oct 23, 2019	SELL	$81.84 - $88.74 $4,092 - $4,437	-50 Reduced 0.88%	5,637 $472,000
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $728 - $850	10 Added 0.18%	5,687 $478,000
Q1 2019 Apr 30, 2019	BUY	$66.22 - $80.06 $728 - $880	11 Added 0.19%	5,677 $454,000
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $27,797 - $31,490	-424 Reduced 6.96%	5,666 $410,000
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $15,871 - $19,146	261 Added 4.48%	6,090 $447,000
Q2 2018 Aug 02, 2018	BUY	$57.57 - $63.54 $335,575 - $370,374	5,829 New	5,829 $356,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.

Account

West Branch Capital LLC Abbott Laboratories Transaction History